Total | Group A (non-metastatic group) | Group B (metastatic group) | |
---|---|---|---|
Number of patients | 167 | 42 | 125 |
Age (median) | 64.0 | 65.0 | 63.0 |
Gender (%) | |||
Male | 124 (74.3) | 29 (69.0) | 95 (76.0) |
Female | 43 (15.7) | 13 (31.0) | 30 (24.0) |
ECOG PS (%) | |||
0 | 79 (47.3) | 33 (78.6) | 46 (36.8) |
1 | 86 (51.5) | 9 (21.4) | 77 (61.6) |
2 | 2 (1.2) | 0 (0.0) | 2 (1.6) |
Histological type (%) | |||
Intestinal type | 60 (35.9) | 10 (23.8) | 50 (40.0) |
Diffuse type | 107 (64.1) | 36 (76.2) | 71 (60.0) |
T-stage | |||
T1 | 9 (5.4) | 7 (16.7) | 2 (1.6) |
T2 | 34 (20.4) | 9 (21.4) | 25 (20.0) |
T3 | 101 (60.5) | 22 (52.4) | 79 (63.2) |
T4 | 23 (13.8) | 4 (9.5) | 19 (15.2) |
N-stage | |||
Nx | 4 (2.4) | 2 (4.8) | 2 (1.6) |
N0 | 22 (13.2) | 12 (28.6) | 10 (8.0) |
N1 | 56 (33.5) | 16 (38.1) | 40 (32.0) |
N2 | 53 (31.7) | 9 (21.4) | 44 (35.2) |
N3 | 32 (19.2) | 3 (19.2) | 29 (23.2) |
Metastatic lesion (%) | |||
≦1 | 135* (80.8) | 40* (95.2) | 95 (76.0) |
2≦ | 32 (19.2) | 2 (4.8) | 30 (24.0) |
Metastatic site (%) | |||
Lymph node | 92* (55.1) | 19* (45.2) | 73 (58.4) |
Liver | 34 (20.3) | 2** (4.8) | 32 (25.6) |
Lung | 8 (4.8) | 0 (0.0) | 8 (6.4) |
Peritoneal dissemination | 43 (25.7) | 3** (7.1) | 40 (32.0) |
Other | 6 (3.6) | 0 (0.0) | 6 (4.8) |